CYP7A1 and metabolic dysfunction-associated steatotic liver disease: It is mediated by enhanced levels of cytochrome P450 CYP27A1 and CYP7A1 isoforms in hepatocytes during NAFLD (Testa et al., 2016; Zhang et al., 2018; Gamba et al., 2019; Chen et al., 2020).